Related Experiment Video
Updated: Mar 8, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Desensitization: Overcoming the Immunologic Barriers to Transplantation
Supreet Sethi1, Jua Choi1, Mieko Toyoda1
1Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Human Leucocyte Antigen (HLA) sensitization hinders kidney transplants. New immunomodulatory therapies improve access for sensitized patients and may help treat antibody-mediated rejection.
Area of Science:
- Immunology
- Nephrology
- Transplantation Science
Background:
- Human Leucocyte Antigen (HLA) sensitization poses a major challenge for kidney transplantation.
- It leads to difficulties in crossmatching and increases the risk of antibody-mediated rejection post-transplant.
Purpose of the Study:
- To review current immunomodulatory therapies for desensitizing HLA-sensitized kidney transplant candidates.
- To analyze emerging biologics and their potential impact on desensitization and antibody-mediated rejection.
Main Methods:
- Literature review of immunomodulatory agents used in desensitization.
- Analysis of clinical data for available and novel biologic therapies.
Main Results:
- Several classes of immunomodulatory agents are available for desensitization, including IgG inactivating agents, anti-cytokine antibodies, costimulatory molecule blockers, complement inhibitors, and plasma cell-targeting agents.
- Novel biologics show promise for improving desensitization outcomes.
Conclusions:
- Immunomodulatory therapies have expanded kidney transplantation access for HLA-sensitized patients.
- Emerging biologics are expected to further enhance desensitization strategies and offer new treatment options for antibody-mediated rejection.
More Related Videos
Related Concept Videos
Cell-mediated Immune Responses
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Kidney Transplant I: Introduction
Drug Toxicity: Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

